The expression of EPCR and key proteins associated with EPCR-dependent signaling (protein S, protein C, thrombomodulin, Factor V, VIII and PAR-1 and PAR-2) was investigated in endometrial and ovarian cancers [47] and compared with benign tumors. Here, PROCR is linked to ovarian carcinoma.